Glucocorticoid modulates high-mobility group box 1 expression and Toll-like receptor activation in obstructive jaundice. 2011

Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.

BACKGROUND Obstructive jaundice is associated with bacterial translocation and inflammatory cytokine induction. It is unknown if toll-like receptors (TLRs) and their upstream molecule high mobility group box-1 (HMGB1) are involved in the pathogenetic mechanism and if glucocorticoid is effective in modulating the process. METHODS A rat model of cholestasis by ligation of the extrahepatic bile duct (BDL) for 2 wk was created. TLRs, interferon regulatory factors (IRFs), IL-6, IL-8, antimicrobial peptide β-defensin, and cathelicidin, as well as HMGB1 expressions were studied by using real-time quantitative reverse transcription-polymerase chain reaction, immunohistochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA). Glucocorticoid treatment was applied to a group of BDL rats. RESULTS Obstructive jaundice for 2 wk was associated with significant up-regulation of TLR1, 2, 4, 6, 7, and 9 mRNA expressions. There were significant increases of liver IRF5, IL-6, and β-defensin 1 mRNA levels in the BDL rats than in the sham and nonoperative control rats, which were associated with significant increase of immunoreactive IRF5 protein staining in the nucleus of Kupffer cells and neutrophils. Hepatic HMGB1 expression and release into serum were significantly elevated in the cholestatic rats than in the sham and control rats. Glucocorticoid treatment significantly decreased hepatic HMGB1 expression and release into serum, which was associated with significantly decreased hepatic TLR4 mRNA expression in the cholestatic rats. CONCLUSIONS The results indicate that obstructive jaundice may induce hepatic HMGB1 expression with activation of TLR4 and a number of downstream signaling molecules, which can be reversed by glucocorticoid administration.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D050835 Interferon Regulatory Factors A family of transcription factors that share an N-terminal HELIX-TURN-HELIX MOTIF and bind INTERFERON-inducible promoters to control GENE expression. IRF proteins bind specific DNA sequences such as interferon-stimulated response elements, interferon regulatory elements, and the interferon consensus sequence. Interferon Regulatory Factor,IRF Transcription Factors,Factor, Interferon Regulatory,Regulatory Factor, Interferon,Transcription Factors, IRF
D051193 Toll-Like Receptors A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS. Receptors, Toll-Like,Toll-Like Receptor,Receptor, Toll-Like,Receptors, Toll Like,Toll Like Receptor,Toll Like Receptors
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
May 2011, Arteriosclerosis, thrombosis, and vascular biology,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
April 2013, Biological psychiatry,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
February 2021, Molecules (Basel, Switzerland),
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
September 2012, Life sciences,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
May 2017, BMC physiology,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
January 2013, PloS one,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
January 2021, Frontiers in veterinary science,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
March 2006, American journal of physiology. Cell physiology,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
March 2022, Endocrine journal,
Ying-Hsien Huang, and Pei-Wen Wang, and Mao-Meng Tiao, and Ming-Huei Chou, and Yung-Ying Du, and Chao-Cheng Huang, and Jiin-Haur Chuang
June 2017, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!